Enter multiple symbols separated by commas

Stocks Pfizer Inc


  • Pfizer-Allergan deal reflects US tax issues: Pro Monday, 23 Nov 2015 | 6:07 PM ET
    Pfizer-Allergan deal reflects US tax issues: Pro

    Scott Colyer, Chairman & CEO of Advisors Asset Management, says Pfizer's decision to move its tax address to Ireland reflects the inabilities of the U.S. Congress to adjust tax codes.

  • WASHINGTON, Nov 23- U.S. politicians condemned Pfizer Inc's deal with Allergan Plc as a tax dodge on Monday, bringing another round of hand-wringing in Washington over the corporate tax code, though legislative action before 2017 is unlikely. Democrats heaped the most criticism on the New York- based drug maker, with Hillary Clinton accusing Pfizer of using...

  • *Pfizer set to buy Allergan. NEW YORK, Nov 23- The dollar rose to an eight-month high on Monday amid heightened expectations that the U.S. Copper fell to its cheapest in six months before recovering.

  • Pfizer, Allergan in $160B combo Monday, 23 Nov 2015 | 5:15 PM ET
    Pfizer, Allergan in $160B combo

    The deal with Pfizer and Allergan is the largest inversion transaction on record. The "Fast Money" traders discuss other potential inversion targets.

  • Pfizer and Chipotle are big market movers Monday, 23 Nov 2015 | 4:29 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Pfizer Inc., down 85 cents to $31.33. Peabody Energy Corp., up 42 cents to $11.71.

  • Stocks close mildly lower; oil, data eyed Monday, 23 Nov 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed mildly lower as investors eyed fluctuations in oil prices and looked ahead to data in the shortened Thanksgiving holiday week.

  • *Pfizer, Allergan drop after biggest-ever healthcare deal. *Alcoa up as Elliott takes stake. After a week when S&P 500 had its best performance of the year, investors were also unimpressed by Monday's economic data and some were concerned that economic growth may be slower than expected and holiday season sales may disappoint, said Stephen Massocca, Chief...

  • WASHINGTON, Nov 23- Democratic politicians condemned Pfizer Inc's tax-avoiding "inversion" deal with Ireland's Allergan Plc on Monday, bringing another round of Washington hand-wringing over corporate taxes, but probably no immediate legislative action. Hillary Clinton, the front-runner for the Democratic presidential nomination, blasted Pfizer for...

  • Pfizer-Allergan by the numbers Monday, 23 Nov 2015 | 3:01 PM ET
    Pfizer-Allergan by the numbers

    Pfizer is buying Allergan for about $160 billion. CNBC's Meg Tirrell reports on the reaction by lobbyists and analysts.

  • Congress should prevent tax inversions: White House Monday, 23 Nov 2015 | 2:59 PM ET
    White House Press Secretary Josh Earnest

    The White House called on Congress to take legislative action to stop companies from conducting tax "inversions."

  • NEW YORK, Nov 23- U.S. drug benefit manager CVS Health said on Monday it would add Amgen Inc's Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Regeneron Pharmaceuticals and Sanofi SA. The FDA approved Repatha and Praluent, made by Regeneron and Sanofi, within weeks of each other last summer for patients...

  • *Pfizer set to buy Allergan for $160 bln. Copper fell to its cheapest in six months before recovering, while London nickel slid to its lowest since 2003. Gold fell nearly one percent towards last week's near-six-year low. "In the context of a market waiting for supply-side cuts, a stronger dollar is only going to weigh on the cost curve and constrain the pace at which...

  • Nov 23- Pfizer Inc's looming deal to buy Botox maker Allergan Plc for more than $150 billion will cap a record-breaking run for mergers and acquisitions in the healthcare sector, taking the cumulative value of deals in 2015 to more than $600 billion. Pfizer's tax-driven takeover of Allergan, which people familiar with the matter said won board approval on...

  • Pfizer to buy Allergan for record $160 billion Monday, 23 Nov 2015 | 2:03 PM ET
    Allergen CEO Brent Saunders (L) and Pfizer CEO Ian Read (R).

    Pfizer's record deal with Allergan will allow the New York-based drug giant to relocate to Ireland to cut its U.S. tax burden.

  • WASHINGTON, Nov 23- The White House declined to comment on Pfizer's acquisition of Allergan, the biggest-ever tax inversion deal, but said Congress should take legislative action to prevent deals where companies lower their taxes by reincorporating overseas.

  • Clinton, Sanders oppose Pfizer-Allergan deal Monday, 23 Nov 2015 | 1:45 PM ET

    WASHINGTON— Hillary Rodham Clinton and Bernie Sanders are bashing plans by Pfizer and Allergan to join together in a $160 billion deal that will create the world's largest drugmaker. Martin O'Malley calls the merger "fundamentally unfair." This story has been corrected to correct spelling of Allergan.

  • 10 things to know about corporate inversions Monday, 23 Nov 2015 | 1:28 PM ET

    WASHINGTON— Pfizer and Allergan are pursuing the biggest buyout in health care history, a $160 billion deal that would essentially send one of the biggest U.S. corporations overseas, or at least its legal domicile and principal executive offices. Under a maneuver known as an "inversion," Pfizer will be able to lower its corporate tax load by reorganizing as a...

  • Democratic presidential candidate Hillary Clinton on Monday bashed Pfizer Inc's deal to buy Allergan PLC, saying she would propose steps to prevent tax inversions and calling on regulators to take tougher action.

  • *Pfizer, Allergan drop after biggest-ever healthcare deal. Pfizer's shares were down 2.1 percent at $31.51, after the company said it would buy fellow drugmaker Allergan in a deal valued at about $160 billion, the biggest ever in the healthcare sector. Allergan fell 2.4 percent to $305.11.

  • 2015: Pfizer Inc. buys Allergan Plc for $146.5 billion. 2014: Medtronic Inc. buys Covidien Plc for $49.66 billion. 2013: Liberty Global Inc. buys Virgin Media Inc. for $17.03 billion.